Porescreen
Porescreen, licence 80122472: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Dermalogica (Canada) Inc.
- NPN or DIN-HM
- 80122472
- Status
- Active licence
- Licence date
- 22 December 2022
- Revision date
- 16 February 2023
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Oxyde de zinc Source : Oxyde de zinc | 10.0 % | Not calculated |
Non-medicinal ingredients
Néopentanoate d'octyldodécyle, C.I. 77491, Méthylpropanediol, Chlorure de sodium, Stéarate de propylène glycol, Silylate de silice, Tocophérols, C.I. 77492, Benzoate d'alkyle en C12 à 15, Huile de graines d'Helianthus annuus (Tournesol), Triglycéride caprylique/caprique, Phénylpropanol, Diisostéarate/poly(hydroxystéarate)/sébacate de poly(glycéryle-4), Linalool, Acide lactique, Caprylyl glycol, Copolymère d'acrylates/méthacrylate d'amonium, Squalène, Acide citrique, Extrait de Chlorella vulgaris, Propanediol, Lauryl PEG-8 Diméthicone, Niacinamide, Esters décyliques d'huile d'olive, Bisabolol, Extrait de Fleur/Feuilles/Tige de Lavandula Angustifolia (Lavande), Extrait de Rosa Damascena, Allantoïne, Salicylate de butyloctyle, Lauryl PEG-10 tris(triméthylsiloxy)silyléthyl diméthicone, Hydroxyde de sodium, Stéarate de magnésium, Poly(oxyéthylène) (10), Glycérine, Silice, C.I. n° 77891, Isododécane, Extrait de fleurs de Chamomille Recutita (Matricaria), Silice hydratée, Sel de mer, Diacétate de glutamate de tétrasodium, Lécithine, Bentonite, Eau, Acétate de cellulose, C.I. 77499
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 0.5 ans | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Absorbs throughout the UVA/UVB spectrum. Broad spectrum (Sun Protection Factor 40 / SPF 40). Sun Protection Factor 40 / SPF 40.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80122472
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.